TP53 and keratoconus: The most promising preclinical models of PDAC include KC mice, which express oncogenic KRAS from the earliest stage of pancreas development [15] and KPC mice, which represent KC mice crossed with mice with non-functional or mutant alleles of p53 gene [16].